Literature DB >> 29402438

Resolution of remitting seronegative symmetrical synovitis with pitting edema (RS3PE) during Nivolumab therapy for non-small cell lung cancer: a case report.

Marco Filetti1, Elisabetta Anselmi2, Serena Macrini2, Francesco Rizzo2, Daniela Iacono3, Raffaele Giusti2, Paolo Marchetti2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29402438     DOI： 10.1016/j.semarthrit.2017.12.013

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN： 0049-0172            Impact factor:   5.532


× No keyword cloud information.
  4 in total

1.  A Case of Anti-PD-L1-associated Remitting Seronegative Symmetric Synovitis With Pitting Edema.

Authors:  Jason M Redman; Logan P Rhea; Lisa Cordes; Helen Owens; Ravi A Madan; Marijo Bilusic; James L Gulley; Jung-Min Lee; William L Dahut; Fatima Karzai
Journal:  Clin Genitourin Cancer       Date:  2019-02-14       Impact factor: 2.872

2.  RS3PE Following Treatment With Combination of Hormonal Therapies Plus Ipilimumab in a Patient With Metastatic Prostate Cancer.

Authors:  Sang T Kim; William A Murphy; Ana Aparicio; Sumit K Subudhi
Journal:  J Immunother Precis Oncol       Date:  2020-05-14

3.  Management of rheumatic complications of ICI therapy: a rheumatology viewpoint.

Authors:  Jan Leipe; Xavier Mariette
Journal:  Rheumatology (Oxford)       Date:  2019-12-01       Impact factor: 7.580

4.  Remitting seronegative symmetrical synovitis with pitting edema syndrome induced by pembrolizumab in patient with urothelial carcinoma.

Authors:  Akihiro Yoshimura; Kazuaki Yamanaka; Rei Tadokoro; Teppei Wakita; Shota Fukae; Takahiro Yoshida; Masahiro Sekiguchi; Hidefumi Kishikawa
Journal:  IJU Case Rep       Date:  2022-05-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.